AMGN Mar 2025 360.000 call
| Previous Close | 11.80 |
| Open | 13.30 |
| Bid | 12.45 |
| Ask | 13.45 |
| Strike | 360.00 |
| Expire Date | 2025-03-21 |
| Day's Range | 13.30 - 14.35 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 446 |
ZacksAmgen (AMGN) Ascends While Market Falls: Some Facts to Note
Amgen (AMGN) closed at $322.67 in the latest trading session, marking a +1.12% move from the prior day.
BloombergRegeneron Shares Head for Worst Month Since 2019 on Legal Ruling
(Bloomberg) -- Regeneron Pharmaceuticals Inc. shares are headed for their biggest monthly drop since mid-2019 after a legal setback that opens the door to an early launch of a competing therapy to the drugmaker’s blockbuster eye treatment, Eylea.Most Read from BloombergClimate Migrants Stand to Overwhelm World’s MegacitiesVanderbilt Leases Struggling NYC Seminary for Campus ExpansionNJ Transit, Amtrak Trains Delayed After Derailment Near NYCWhere Cargo Bikes Are Freeing Cities From Polluting Van
Insider MonkeyAmgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts
We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued wide moat stocks. The US economy was able to pass its first soft-landing test by exhibiting resilience through the […]
